BioLife Solutions Executes Supply Agreement with Celyad
![T-cell graphic](https://www.biolifesolutions.com/wp-content/uploads/2023/01/Cryopreservation-cell.jpg)
BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers Proprietary Clinical Grade Cell Freeze Media Enables Long-Term Storage and Distribution of Engineered Cell-Based Therapies BioLife is pleased to announce that it has executed a long term supply agreement with NASDAQ-listed Celyad, […]